Cardiovascular Systems Stock Price and Value Analysis

Should you buy Cardiovascular Systems stock? (NasdaqGS:CSII). Let's see how it does in our automated value investing analysis system.

CSII Free Cash Flow Trend

Free Cash Flow trendline for CSII
Free Cash Flow trendline for Cardiovascular Systems

Hmm, we can't give any reliable projection for Cardiovascular Systems's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

AdvantagesDisadvantagesNeutral
  • This company is solid.
  • This company has wild ups and downs.
  • This stock looks overpriced.
  • This company is not making money.
  • This company pays no dividend.

Inside the CSII Numbers

CSII Price
(Cardiovascular Systems stock price per share)
$48.22
[?] PE Ratio versus Sector 3828% higher than other Healthcare stocks
[?] PE Ratio versus Industry 100% lower than other Medical Devices stocks
[?] Free Cash Flow Jitter 42%

Is Cardiovascular Systems Stock on Sale?

Based on our analysis, we believe that you should not buy Cardiovascular Systems right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy CSII Stock?

Does Cardiovascular Systems have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.